...肺动脉高压在病理形态学上难以区分,提示可能是肺循环对损伤的共同反应的一个终末过程,肺血管重构(pulmonary vascular remodeling, PVR)是PH的一个基本病理学特征[1]。更有学者提出PVR是PH治疗的标靶[2]。
基于8个网页-相关网页
...高压在病理形态学上难以区分,提示可能是肺循环对损伤的共同反应的一个终末过程,肺血管重构(pulmonary vascular remodeling, PVR)是PH的一个基本病理学特征[1]。更有学者提出PVR是PH治疗的标靶[2]。
基于2个网页-相关网页
Lately studies found that statins can conquer these limiting factors, abate and even reverse PAH and pulmonary vascular remodeling.
最近研究发现他汀类药物能克服上述限制因素，且能有效减轻甚至逆转PAH和肺血管重构。
参考来源 - 肺动脉高压药物治疗的新认识—《中国医药导报》—2008年第15期—龙源期刊网The results indicated that 5-HT played an important role in pulmonary vascular remodeling.
上述结果表明:5-HT在肺动脉高压肉鸡肺血管重构发生过程中起着重要的作用。
参考来源 - 肺动脉高压肉鸡肺小动脉中膜5·2,447,543篇论文数据，部分数据来源于NoteExpress
结论：泻肺化痰祛瘀法具有降低肺动脉压、防止肺血管重构的作用。
Conclusion: TCM drugs for purging the lung and removing phlegm and blood stasis could decrease pulmonary artery pressure and might prevent pulmonary vessel from reconstitution.
前言： 肺动脉高压的基本病理改变有三个方面：肺血管收缩、肺血管重构和肺小血管内微血栓形成。
The basic pathological alteration of pulmonary hypertension involves three dependent elements:pulmonary vasoconstriction, pulmonary vascular remodeling and pulmonary microvascular thrombogenesis.
低氧组大鼠肺血管显微及超微结构发生明显改变，有肺血管结构重构形成。
Microstructure and ultrastructure of pulmonary arteries changed obviously in hypoxic rats with the development of hypoxic pulmonary vascular structural remodeling.
应用推荐